AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (505)	8/19/1997 10:47:00 AM
From: tonyt	of 2173

Henry, now you are just posting incorrect information. Vector did not maintain a buy, they upgraded to a buy. I know you read the news wires, so I really don't understand why you did this (....maybe I do, don't bother to explain): RESEARCH ALERT-Amylin <AMLN.O> upgraded by Vector CHICAGO, Aug 19 (Reuter) - Vector Securities analyst Mike King said he upgraded Amylin Pharmaceuticals Inc to buy from attractive. --Tony

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next